Significant risk of venous thromboembolism associated with targeted anti-myeloma immunomodulatory drugs. Comment on "Targeted anti-cancer agents and risk of venous thromboembolism".

IF 7.9 1区医学 Q1 HEMATOLOGY

Haematologica Pub Date : 2025-10-01 Epub Date: 2025-03-06 DOI:10.3324/haematol.2025.287442

Catherine Duane, Siobhan Glavey, John Quinn, Philip Murphy

引用次数: 0

查看原文本刊更多论文

静脉血栓栓塞的显著风险与靶向抗骨髓瘤免疫调节药物相关。评论：靶向抗癌药物与静脉血栓栓塞的风险。

不可用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Haematologica 医学-血液学

CiteScore

14.10

自引率

2.00%

发文量

349

审稿时长

3-6 weeks

期刊介绍： Haematologica is a journal that publishes articles within the broad field of hematology. It reports on novel findings in basic, clinical, and translational research. Scope: The scope of the journal includes reporting novel research results that: Have a significant impact on understanding normal hematology or the development of hematological diseases. Are likely to bring important changes to the diagnosis or treatment of hematological diseases.